The new LDL-C target <55 mg/dL is achieved by less than 40% of very high risk patients with familial hypercholesterolaemia despite receiving PCSK9 inhibitors: real world data
Authors: L Rallidis, C Vlachopoulos, E Liberopoulos, I Skoumas, E Kiouri, I Koutagiar, G Anastasiou, N Kosmas, D Tousoulis, E Iliodromitis